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Perinatal programming, a dominant theory for the origins of cardiovascular disease, proposes that environmental stimuli
inﬂuence developmental pathways during critical periods of prenatal and postnatal development, inducing permanent changes
in metabolism. In this paper, we present evidence for the perinatal programming of asthma via the intestinal microbiome. While
epigenetic mechanisms continue to provide new explanations for the programming hypothesis of asthma development, it is
increasingly apparent that the intestinal microbiota plays an independent and potentially interactive role. Commensal gut bacteria
are essential to immune system development, and exposures disrupting the infant gut microbiota have been linked to asthma. This
paper summarizes the recent ﬁndings that implicate caesarean delivery, breastfeeding, perinatal stress, probiotics, and antibiotics
as modiﬁers of infant gut microbiota in the development of asthma.
1.Introduction
Supported by evidence from farm lifestyle and endotoxin
studies [1], the hygiene hypothesis has changed our under-
standing of the environmental origins of asthma and allergic
disease.However,itfailstoexplainthecoexistingepidemicin
autoimmune disease or the high rates of asthma among the
urban poor in the United States. This limitation has moti-
vated the continued search for alternate explanations such as
the microﬂora hypothesis [2] and the developmental origins
hypothesis for health and disease (DOHaD) [3]. Originating
as the Barker hypothesis, DOHaD or “perinatal program-
ming” has been a dominant theory for the association
between low birth weight and cardiovascular or metabolic
disease in later life [3]. In this paper, we present evidence
for the perinatal programming of childhood asthma, with
a focus on the intestinal microbiome. We begin with a
discussion and examples of perinatal programming and epi-
genetics,highlighting environmentalexposuresduring the in
utero and ex utero time periods that are potential stimuli for
the early programming of asthma. More detailed discussion
is provided on the postnatal development of immunity and
its interaction with the intestinal microbiome, with evidence
for the long-term impact of 5 perinatal exposures: caesarean
section delivery, breastfeeding, antibiotics, probiotics, and
perinatal stress.
2. PerinatalProgrammingof
DiseaseandEpigenetics
The DOHaD hypothesis proposes that nutrition and other
environmental stimuli or insults can inﬂuence developmen-
talpathwaysduringcriticalperiodsofprenatal,andpostnatal
development, and subsequently induce permanent changes
in metabolism and disease susceptibility [3, 4]. While coined
by Barker as the “fetal origins” hypothesis [5], the realization
that human development extends into the postnatal period
led to a change in nomenclature to the “developmental
origins” hypothesis. “Programming” is another common
term for the DOHaD hypothesis. The DOHaD approach
was initially focused on early-life nutrition as a pathway for
obesity and related metabolic abnormalities but has since
been expanded to include the psychobiological eﬀectsof fetal
and infant exposure to stress [3]. In fact, overexposure of
t h ef e t u st om a t e r n a ls t r e s sa n dg l u c o c o r t i c o i d sh a sb e e n
proposed asanalternativetofetalundernutrition, toaccount2 Clinical and Developmental Immunology
for the association between the prenatal environment and
the development of cardiovascular, metabolic, and neuroen-
docrine phenotypes.
Based on evolutionary concepts, the DOHaD theory
surmises that predictive adaptive responses of the fetus to
in utero environmental cues promote a phenotype that is
optimally suited for the postnatal environment [6]. If the
prediction is correct, there will be a good match between
the adopted phenotype and the postnatal environment. If
the prediction is poor, there will be a mismatch between
the phenotype produced and the environment experienced,
resulting in negative health consequences. For example, con-
strained fetal or infant growth from malnutrition followed
by enhanced nutrition during infancy or later childhood
leads to metabolic abnormalities, such as insulin resistance.
Other DOHaD-informed studies have detected smaller brain
hippocampal volume (a risk factor for depression and
psychopathology) in individuals who were born low birth
weight and exposed to postnatal adversity [3].
Epigeneticmechanisms—theimprintingofenvironmen-
tal experiences on infant gene expression—are increasingly
thought to be at the root of the DOHaD hypothesis [7].
Speciﬁcally, epigenetic modiﬁcations aﬀect gene expression
without altering DNA sequence. There is strong evidence
that early environmental exposures can activate or silence
genes by altering DNA methylation, histone acetylation
and methylation, and chromatin structure [3]. Since these
modiﬁcations regulate the degree of DNA coiling and acces-
sibility for transcription, they determine gene expression.
DNA methylation is the best-characterized epigenetic mod-
iﬁcation [4], occurring at cytosine-guanine dinucleotides
(CpGs). Site-speciﬁc and regional changes in CpG methy-
lation are often highly correlated with gene expression. Fol-
lowing DNA replication, the original pattern of CpG methy-
lation is restored, ensuring the perpetuation of epigenetic
information in replicating cells.
The epigenetic phenomenon is clearly demonstrated by
evidence of diet-induced DNA methylation during mouse
fetal development and subsequent changes to coat color and
body weight in the oﬀspring of mothers who consume a
high-soy diet during pregnancy [8]. DNA hypomethylation
has consistentlybeen documented in rat models ofintrauter-
inegrowthretardation[9].Inhumans,assisted-reproduction
studieshaveshownthatinappropriateepigeneticreprogram-
mingcanincreasetheriskofsomedevelopmentalsyndromes
[4]. Altered DNA methylation has also been observed in
response to maternal undernutrition during pregnancy and
following child abuse [9].
3. PerinatalProgrammingof Asthma
Since immune and lung development occur largely in utero
and during early childhood [10], perinatal programming
is a plausible pathway for allergic and respiratory disease
[11, 12]. Indeed, fetal exposure to maternal smoking during
pregnancy, separately from postnatal exposure to second-
hand smoke, can increase risk for asthma in oﬀspring [13,
14]. As described in the review by Hylkema and Blacquiere
[13], evidence is accumulating to show that tobacco smoke
can modify fetal lung development and immune function.
Other intrauterine exposures, such as maternal stress or
adherence to a Mediterranean diet (high in folic acid and
antioxidants), are also known to modify the risk of allergic
disease in the oﬀspring [15, 16].
Recent studies show that prenatal exposures can activate
or silence immune-related genes through epigenetic mecha-
nisms. Breton et al. found signiﬁcantly lower global methyla-
tion of DNA in young schoolchildren with in utero exposure
to maternal smoking, with hypermethylation at speciﬁc gene
loci [17], and several examples of diet-induced modiﬁcation
of DNA methylation have been provided in the recent
review by Attig et al. [9]. For example, maternal folic acid
supplementation has been found to increase methylation of
the insulin-like growth factor 2 gene in oﬀspring, and animal
studies show that folic acid can prevent hypomethylation
resulting from maternal undernutrition. While there is
evidence that immune system development (speciﬁcally T-
cell diﬀerentiation) is under epigenetic regulation [18, 19],
and epigenetic changes (such as DNA methylation) have
been found in children with asthma [20, 21], it remains to
be determined whether epigenetic modiﬁcations mediate the
eﬀects of maternal smoking, stress, and diet on child asthma.
As noted earlier, the DOHaD paradigm is not lim-
ited to the in utero time period. This brings us to the
main focus of our paper: the role of gut microbiota in
the perinatal programming of asthma. Mounting evidence
indicates that the continuous and predictable presence of
commensal bacteria (microbiota) in the human intestine
plays an important role in shaping the immune system
during infancy [22, 23]. Indeed, studies have shown that
commensalgutmicrobesinteractwithimmunecellstocreate
and maintain host tolerance, inﬂuencing both innate and
adaptive immune responses [24]. As detailed in later sections
of the current paper, this “microﬂora hypothesis” has been
put forward as an example of early-life programming of
allergy and asthma [24, 25]. A key characteristic of metabolic
programming or imprinting is the need to distinguish
primary “imprints” from secondary physiological alterations
that arise in response to primary imprints. This requires
evidence that primary imprints are present directly after
the programming period as well as in later life [4]. With
this criterion in mind, we attempt to advance the DOHaD
thesis of asthma by presenting evidence on how early-life
environmental modiﬁcations of the intestinal microbiome
can result in permanent changes to microbiota composition
and immunity.
4. Immune SystemDevelopment
andGut Microbiota
Development of the immune system begins in utero and
continues postnatally. Human lymphocytes ﬁrst appear in
the liver within several weeks of conception and are evident
in the thymus by 10–12 weeks of gestation [26]. They are
responsive to mitogen stimulation by the second trimester
[27], and allergen-speciﬁc responses have been documented
as early as 22 weeks gestation [28]. At birth, cytokine res-
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[29], and many aspects of neonatal immune function re-
main immature, including Th1 cytokine production, T-cell
signaling and eﬀector functions, monocyte responsiveness,
and antigen presentation by dendritic cells [30].
Pregnancy itself is associated with a transient depression
of maternal cell-mediated immunity [31] and predominance
of Th2 cytokines at the maternofetal interface [32], which
are thought to protect the fetus from immunologic rejection
by the mother [33]. The maternal environment during preg-
nancy promotes Th2 polarity in the fetal immune system,
with transition to a nonallergic Th1 phenotype occurring
after birth. If this transition is delayed or impaired during
early postnatal life, there is an increased risk of atopic disease
including asthma [30].
Following birth, maternal inﬂuence on the developing
infant immune system continues through breastfeeding.
Maternal antibodies (including IgG and IgA) are transferred
in breast milk, providing passive immunity to oﬀspring dur-
ing infancy. Immune cells (neutrophils and macrophages)
and cytokines (interleukins, TNFα,a n dT G F β) are also pre-
sent in breast milk, along with bactericidal enzymes and
antiviral factors [34]. Nutrients and growth factors in breast
milk have been shown to regulate the innate immunity
[35], while fatty acid composition can modulate neonatal
cytokine responses [36]. Despite the many protective factors
transmitted in breast milk, it remains controversial whether
breastfeeding is protective against asthma development in
the infant. While several studies have shown that asthma risk
is reduced in breast-fed infants [37–40], others claim there is
no association [41, 42], and an inverse relationship has been
demonstrated for children with maternal history of asthma
[43, 44]. Wright et al. found that in school age children
born to asthmatic mothers, longer duration of exclusive
breastfeedingwasassociatedwithanincreasedriskofasthma
[43].Theseﬁndingsaresupportedbyanimalstudiesshowing
that breast milk can mediate the transmission of asthma
risk from mother to oﬀspring [45], possibly through the
delivery of high concentrations of Th2 cytokines. Thus,
while breastfeeding unquestionably provides nutritional and
immunological beneﬁts to the developing infant, its role in
the perinatal programming of asthma remains controversial.
In addition to maternal immunogenic factors transferred
during and after pregnancy, it is increasingly apparent
that postnatal microbial exposure provides an essential
source of immune stimulation. Colonization of the intestine
begins during the birthing process, and mounting evidence
indicates that these commensal bacteria play a central role
in programming the neonatal immune system [23, 24]. For
example,gutmicrobeshavebeenshowntoinduceregulatory
Tcellsthathelpguidethehost’sTh1/Th2balance,andrecog-
nition of microbiota-derived peptides by mucosal receptors
has been shown to enhance systemic innate immunity [24].
It has also been hypothesized that commensal gut microbes
mayproducemetabolitescapableofepigeneticmodiﬁcations
[46]; however, this remains to be proven experimentally.
Microbial metabolites include short chain fatty acids [47],
which could inﬂuence asthma development, since maternal
and infant dietary fatty acid composition have been associ-
ated, albeit inconsistently, with childhood asthma [48].
Since the early 2000s, we have known that infants who
ultimately develop allergic disease harbor a distinct gut
microbiota [49, 50], and new evidence suggests this may
also be true for asthma. Two birth cohort studies have
reported that gut microbiota proﬁles in the ﬁrst month
of life can predict recurrent wheeze or possible asthma
later in childhood [51, 52]. In particular, colonization with
the pathogen Clostridium diﬃcile has been associated with
increased future risk of wheeze or asthma [51, 53]. Results
fromongoingstudiesemployingnew“nextgeneration”tech-
nologiesarehighlyanticipatedandpromisetovastlyimprove
our understanding of infant gut microbiota composition,
including how it may contribute to asthma development.
In parallel, researchers are increasingly focusing on expo-
sures that inﬂuence the developmental programming of the
intestinal microbiome.
5. PerinatalProgrammingof the
IntestinalMicrobiome
A groundbreaking international study has shown that adult
gut microbiota can be classiﬁed according to a limited num-
ber of distinct microbial compositions or “enterotypes” that
respond diﬀerently to diet and drug intake [54]. Enterotypes
are likely established during early life, explaining why neona-
tal gut microbiota composition has a lasting eﬀect on health
and immunity [22]. Indeed, research has shown that gut
microbiota proﬁles during infancy can predict overweight
at school age [49], and accumulating evidence indicates
that asthma prediction may also be possible [51, 52]. From
the DOHaD perspective, these associations could reﬂect
developmental “mismatch” scenarios, whereby disturbances
toearly-lifegutmicrobiotacausetheinfanttobemaladapted
for future microbial exposures, leading to inappropriate
immune responses that ultimately contribute to chronic
disorders such as overweight or asthma. Consequently,
there is growing interest in learning which environmental
exposures inﬂuence microbiota development in the infant
gut. The KOALA birth cohort studies in The Netherlands
have identiﬁed several perinatal exposures that alter the
intestinal microbiota at one month of age [55, 56]. In this
paper, we have chosen to focus on 5 perinatal exposures,
for which there is the most evidence regarding associations
with the development of asthma (Table 1): caesarean section
delivery,exclusivityofbreastfeeding,useofantibiotics,useof
probiotics, and perinatal stress.
5.1. Caesarean Section Delivery. The newborn’s ﬁrst micro-
bial exposure is to maternal microbiota during birth,
which lays the foundation for intestinal colonization. Cae-
sarean section delivery prevents exposure to maternal fecal
microbes, resulting in fewer intestinal Biﬁdobacteria and
Bacteroides [57, 58]. In the absence of these commensal
species, infants delivered by caesarean section are more
frequently colonized by the asthma-associated pathogen
C. diﬃcile [56]. Studies have reported disturbed fecal
microbiota proﬁles in caesarean section delivered infants
beginning at 1 day after birth and persisting to 6 months
of age [58–60], with one report documenting microbial4 Clinical and Developmental Immunology
Table 1: Summary of perinatal exposures that may inﬂuence the programming of asthma via modiﬁcation of infant gut microbiota.
Perinatal exposure Eﬀect on gut microbiota Eﬀect on asthma development
Caesarean delivery
Prevents exposure to maternal fecal microbes.
↓ Biﬁdobacteria and Bacteroides [57, 58],
↑ C. diﬃcile [53, 56].
Diﬀe r e n c e sm a yp e r s i s tf o ry e a r s[ 58–61].
Increases risk of asthma [62]; recent studies
inconsistent [53, 63, 64].
Breastfeeding
Confers beneﬁcial gut microbiota through prebiotic
properties [66] or direct transfer of bacteria [67, 68].
↑ Biﬁdobacteria, ↓ C. diﬃcile [56, 57, 65].
Protects against asthma [69–73], except when
mother is atopic [43, 44].
Antibiotics
Suppresses commensal bacteria, permits emergence of
C. diﬃcile [22, 56, 77].
Disturbance may persist for years [78, 79].
Even indirect exposure is harmful [57].
Increases risk of asthma [80–83], except when
parents are atopic [82, 88].
Even indirect exposure is harmful [55, 84–87].
Some studies may be confounded [91, 92].
Probiotics Direct or indirect exposure beneﬁcially inﬂuences gut
microbiota composition [94–96].
Protects against asthma in animal studies [97, 98];
human trials inconclusive [100–103].
Perinatal stress Causes transient and long-lasting changes to gut
microbiota in animal studies [104–107]. Increases risk of asthma [114, 115].
“Indirect exposure” refers to exposure occurring via the mother, during pregnancy or lactation.
diﬀerences a full 7 years after delivery [61]. In their 2008
meta-analysis, Thavagnanam et al. reported a 20% increase
of asthma in children born by caesarean section [62], but
thereis considerableheterogeneityamong recentstudies. For
example, a UK medical record linkage study documented
that caesarean delivery was not associated with hospital
admission for asthma beyond age 1 [63], while a Canadian
study found an association with asthma at age 9 though it
was limited to ﬁrst-time caesarean section only [64]. New
evidence for the birth mode-microbiota-asthma pathway has
recently emerged from a study employing mediation analysis
to show that the eﬀects of caesarean delivery on asthma
development are mediated by C. diﬃcile [53]. As this study
was limited to just 5 bacterial species, it is likely that other
yet-to-be-identiﬁed bacteria also contribute to this pathway
for the perinatal programming of asthma.
5.2. Exclusivity of Breastfeeding. Following birth, exclusive
breastfeeding confers “beneﬁcial” gut microbiota to infants,
including increased colonization by Biﬁdobacteria and
reduced prevalence and abundance of C. diﬃcile compared
to formula-fed infants [56, 57, 65]. These beneﬁts have
been attributed to the prebiotic properties of human-milk
oligosaccharides [66] or the transfer of intestinal bacteria
from mother to infant through breast milk [67]. Indeed,
new research indicates that breast milk contains a collection
of bacteria more diverse than previously thought [68].
Concurrently, new studies around the world continue to
ﬁnd that breastfeeding protects against recurrent wheeze and
asthma in later childhood [69–73]; however, these beneﬁts
may not apply when the nursing mother is atopic [43, 44].
This phenomenon may be related to microbiota, since the
breast milk of allergic mothers has been reported to contain
signiﬁcantly lower amounts of Biﬁdobacteria compared with
nonallergic mothers, and their infants have concurrently
lower counts of fecal Biﬁdobacteria [74]. The DOHaD
paradigm would describe this scenario as a dietary “mis-
match”, whereby infants of atopic mothers initially receive
low amounts of Biﬁdobacteria via breast milk, followed by
exposure to higher levels of dietary bacteria after weaning.
Since Biﬁdobacteria inﬂuence early immune development
(including IgA production and cytokine responses) [75, 76],
infants who are not suﬃciently exposed to Biﬁdobacteria
in breast milk may have inappropriate immune responses
to microbial exposures later in childhood, leading to atopic
disorders including asthma.
5.3. Use of Antibiotics. After breast milk and other nutri-
tional supplements, antibiotics are the next most commonly
ingestedsubstancesbyinfants.Antibioticsaﬀectcolonization
of the intestine by suppressing commensal bacteria and
causing the emergence of asthma-associated pathogens such
as C. diﬃcile [22]. Research shows that antibiotic use in
the immediate period after birth can severely alter gut
microbiota in infants [56, 77], and evidence from long-
term studies suggests that these perturbations could last
for months, if not years [78, 79]. Indirect exposure is also
relevant, since gut microbial diversity is reduced in infants
born to mothers who received antibiotics during pregnancy
or while breastfeeding [57]. In parallel, new studies continue
to ﬁnd that early-life antibiotic exposure is associated with
increased risk for wheeze or asthma later in childhood [80–
83]. This association is upheld when antibiotic exposure
occurs in utero [84–86], during the neonatal period [87],
or through breastfeeding [55]; however, two studies have
demonstrated that the antibiotic-asthma association is lim-
ited to children who are not already genetically predisposed
to the disease [82, 88]. Once again, this phenomenon may
be related to microbiota, since infants of atopic mothers
inherit low levels of commensal bacteria [74] such that
antibiotic exposure would be relatively less disruptive than
for infants with “normal” gut microbiota. Infants of atopic
mothers may also be more frequently colonized by C. diﬃcile
[53, 89, 90]; therefore, emergence of this asthma-associated
pathogen may not rely on antibiotic disturbance in these
children.Clinical and Developmental Immunology 5
Recently, two systematic reviews have emphasized that
the association between antibiotic use and subsequent
asthma development is subject to confounding by reverse
causation (because antibiotic treatment often occurs in
response to respiratory symptoms) and confounding by
indication (because respiratory tract infections leading to
antibiotic use may be the underlying trigger for asthma
development) [91, 92]. Despite potential confounding in
many of the studies reviewed, the authors acknowledged
that a causal relationship between antibiotic exposure and
subsequent asthma development remains plausible, since
a signiﬁcant pooled estimate of eﬀect was observed for
studies that adequately adjusted for respiratory infections
[92]. Finally, if disturbance of gut microbiota is indeed
the mechanism for the antibiotic-asthma association, then
the timing, dose, and type of antibiotics are likely to be
important. Future studies of large, prospective cohorts that
address these details and adjust for respiratory infections
are needed to deﬁnitively conﬁrm the eﬀect of antibiotic
exposure on the perinatal programming of asthma.
5.4. Use of Probiotics. Along with a growing appreciation
for the role of gut microbiota in immune development and
health outcomes, there is increasing interest in the therapeu-
tic potential of probiotics (live, nonpathogenic bacteria that
confer health beneﬁts when ingested) for asthma and other
immune-related disorders [93]. Studies have shown that
administration of probiotics to pregnant women, nursing
mothers, or newborns can inﬂuence the establishment and
composition of infant gut microbiota [94–96]. In paral-
lel, probiotics have shown promising immunomodulatory
eﬀects in animal studies, where perinatal maternal supple-
mentation [97] and direct supplementation of neonates [98]
have been found to attenuate allergic airway responses in
oﬀspring. However, despite this evidence, clinical trials in
humans have been highly variable. While there is reasonable
evidence that probiotics may be useful in the treatment
or prevention of allergic rhinitis [99], there have been no
conclusive studies for asthma to date [100]. Recent reports
indicatethatprobioticshadnoeﬀectonasthmadevelopment
[101], airway inﬂammation [102], or asthma-related events
[103]. Thus, while they clearly inﬂuence infant gut micro-
biota, it remains to be determined whether probiotics play a
role in the perinatal programming of asthma.
5.5. Perinatal Stress. Infants constantly encounter new
situations; some of these will induce more stress than
others. There is intriguing evidence from animal studies that
stressful events during infancy have the capacity to modify
gut microbiota. Using rhesus monkeys, Bailey and Coe
were the ﬁrst to report that disruption of the mother-infant
bond could alter the intestinal microbiota of infants [104].
This eﬀect was transient, lasting several days after maternal
separation, but the same authors later showed that moderate
maternal stress during pregnancy could disrupt infant gut
microbiota for six months or longer [105]. Rodent studies
support these ﬁndings, showing that frequent maternal
separation in the ﬁrst weeks of life is associated with altered
gut microbiota in adolescence [106, 107]. New research
suggests that it may be possible to mitigate maternal stress-
induced eﬀects with prebiotic supplementation during the
neonatal period [108]; however, epigenetic mechanisms
might also be involved, since rat pups of mothers that
exhibited more frequent grooming and licking were found
to have diﬀerences in DNA methylation, compared to the
oﬀspring of less attentive mothers [109]. Although human
intestinal microbiome changes have been noted following
emotional stress in adults [110, 111], stress-microbiome
pathways have not been explored in infants.
Solid evidence exists for the association of stress and
asthma. As shown in several studies conducted by Miller
and Chen, stressful life events and a harsh family climate
in early life can have long-term eﬀects, resulting in elevated
proinﬂammatory cytokines and glucocorticoid resistance in
adolescents [112, 113]. Studies of allergic immune proﬁles in
cord blood indicate that prenatal maternal stress modulates
fetal innate and adaptive immune responses [16]. In addi-
tion, maternal anxiety during pregnancy [114] or parental
stress during infancy [115] have been found to increase the
likelihood of asthma at school age. It remains to be seen
whether gut microbiota, and/or epigenetic mechanisms, are
involved in these associations.
6. Summary
In this paper, we have presented evidence for the perinatal
programming of asthma via the intestinal microbiome—a
relatively new perspective that has evolved alongside modern
technologies for the study of microbial communities. While
epigenetic mechanisms continue to provide new explana-
tions for the DOHaD theory of asthma development, it is
increasingly apparent that the intestinal microbiota plays an
independentandpotentiallyinteractiverole.Commensalgut
bacteria are essential to immune system development, and
exposures disrupting the infant gut microbiota have been
linked to asthma. Well-designed prospective birth cohort
studies will be required to fully characterize the longstand-
ing impact of caesarean delivery, breastfeeding, antibiotics,
probiotics, and perinatal stress on asthma development
and to empirically validate the “microﬂora programming
hypothesis” in this context.
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